Rchr
J-GLOBAL ID：201401009106568800   Update date: Oct. 24, 2024

Tanaka Hirokazu

タナカ ヒロカズ | Tanaka Hirokazu
Affiliation and department：
Kindai University Faculty of Medicine Department of Medicine

About Kindai University Faculty of Medicine Department of Medicine


Homepage URL  (1)： http://kaken.nii.ac.jp/d/r/40360846.ja.html
Research field  (1)： Hematology and oncology
Research keywords  (17)： 造血 ,  活性酸素種 ,  造血器腫瘍 ,  NF-κB ,  アポトーシス ,  細胞周期 ,  造血幹細胞 ,  鉄過剰 ,  ストローマ細胞 ,  鉄・硫黄クラスター ,  白血病幹細胞 ,  分化 ,  P38MAPK ,  アナモルシン ,  ES細胞 ,  白血病 ,  白血病原因遺伝子
Research theme for competitive and other funds  (13)：
  • 2023 - 2026 変異受容体型チロシンキナーゼの細胞内輸送制御による白血病治療薬の開発研究
  • 2022 - 2025 治癒を目指したCML幹細胞の特性解析
  • 2020 - 2023 多発性骨髄腫の病態形成に関わる抗腫瘍免疫機構の解析研究
  • 2018 - 2021 Characterization molecular and immunologic features of CML stem cells for treatment-free remission.
  • 2016 - 2019 Analysis of novel pathogenesis caused by disorder of immature hematopoietic cells in multiple myeloma
Show all
Papers (177)：
  • Hayato Kaida, Takaaki Chikugo, Hirokazu Tanaka, Kazunari Ishii. 18 F-FDG Uptake in Pancreatic AL Amyloidosis Associated With Multiple Myeloma. Clinical nuclear medicine. 2024. 49. 8. 781-783
  • Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, Shin-Ichi Fuchida, Kensuke Ohta, Yuji Shimura, Satoru Kosugi, Ryosuke Yamamura, Mitsuhiro Matsuda, Hitoshi Hanamoto, et al. The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients. Cancer immunology, immunotherapy : CII. 2024. 73. 7. 135-135
  • Ayumi Kondo, Hirokazu Tanaka, Shinya Rai, Hiroshi Shima, Itaru Matsumura, Toshio Watanabe. Depletion of Ppp6c in hematopoietic and vascular endothelial cells causes embryonic lethality and decreased hematopoietic potential. Experimental hematology. 2024. 133. 104205-104205
  • Naokazu Nakamura, Nobuyoshi Arima, Teruhito Takakuwa, Satoshi Yoshioka, Kazunori Imada, Kentaro Fukushima, Masaaki Hotta, Shin-Ichi Fuchida, Junya Kanda, Nobuhiko Uoshima, et al. Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study. Annals of hematology. 2024
  • Yuji Shimura, Hirohiko Shibayama, Aya Nakaya, Ryosuke Yamamura, Kazunori Imada, Hitomi Kaneko, Hitoshi Hanamoto, Shin-Ichi Fuchida, Hirokazu Tanaka, Satoru Kosugi, et al. Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum. International journal of hematology. 2023
ｍore...
MISC (9)：
  • Aya Nakaya, Takae Kohara, Hirohiko Shibayama, Yoshiyuki Onda, Junya Kanda, Hitomi Kaneko, Kazunori Imada, Toru Kida, Satoru Kosugi, Jun Ishikawa, et al. Retrospective Multi-center Study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum Registry. BONE MARROW TRANSPLANTATION. 2020. 55. SUPPL 1. 560-561
  • 岩田 吉生, 森田 泰慶, 辻 潔, 頼 晋也, 田崎 貴之, 井上 宏昭, 谷口 康博, 藤本 昂, 田中 宏和, 芦田 隆司, et al. 脳静脈洞血栓症を合併し、開頭減圧術・術後エクリズマブ投与が有効であったPNHの一例(Post-operative treatment with eculizumab for PNH presenting as cerebral venous sinus thrombosis). 臨床血液. 2018. 59. 9. 1765-1765
  • 藤原 亮介, 田中 宏和, 芹澤 憲太郎, 金子 仁臣, 志村 勇司, 太田 健介, 淵田 真一, 中谷 綾, 諫田 淳也, 八木 秀男, et al. KMFに登録されたボルテゾミブとIMiDs両剤に抵抗性の再発骨髄腫の予後解析(Clinical outcomes of relapsed myeloma, dual refractory to bortezomib and IMiDs in KMF registry). 臨床血液. 2018. 59. 9. 1739-1739
  • 田中 宏和, 芹澤 憲太郎, 中谷 綾, 金子 仁臣, 太田 健介, 小杉 智, 八木 秀男, 花本 仁, 淵田 真一, 志村 勇司, et al. 症候性骨髄腫1414例の後方視的解析 関西骨髄腫フォーラムからの最新報告(Retrospective analyses of 1,414 symptomatic multiple myeloma cases: update from Kansai Myeloma Forum). 臨床血液. 2018. 59. 9. 1510-1510
  • 太田健介, 山村亮介, 田中宏和, 柴山浩彦, 小原尚恵, 中谷綾, 小杉智, 木田亨, 淵田真一, 新堂真紀, et al. Kansai Myeloma Forumに登録されたMGUSと無症候性骨髄腫644例の臨床経過の解析. 臨床血液. 2016. 57. 9. 1533-1533
ｍore...
Patents (2)：
Books (2)：
  • Recent trends in basic research on myeloma initiating cells.
    2022
  • Novel therapeutic approach for leukemic stem cells
    2011
Lectures and oral presentations  (98)：
  • Gilteritinib treatment for extramedullary relapse of FLT3-ITD acute myeloid leukemia
    (日本造血細胞移植学会総会プログラム・抄録集 2021)
  • Clinical usefulness of Letermovir for patients with stem cell transplantation
    (日本造血細胞移植学会総会プログラム・抄録集 2021)
  • CMML様の病型移行を来したMDSに対してアザシチジンが有効であった1例
    (臨床血液 2021)
  • Retrospective Multi-center Study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum Registry
    (BONE MARROW TRANSPLANTATION 2020)
  • Outcomes of allo-SCT for patients in non-remission especially with chemoresistance
    (日本造血細胞移植学会総会プログラム・抄録集 2020)
ｍore...
Education (2)：
  • 1997 - 2001 大阪大学大学院 医学系研究科
  • 1989 - 1995 Hamamatsu University School of Medicine
Professional career (1)：
  • 医学博士 (大阪大学)
Work history (1)：
  • 2023/04 - 現在 Kindai University Faculty of Medicine Department of Medicine
Association Membership(s) (5)：
American Society of Hematology ,  THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY ,  THE JAPAN SOCIETY FOR TRANSPLANTATION ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM